Leishmaniasis;Leishmaniosen

Deutsche Medizinische Wochenschrift

Volumn 124, Issue 4, 1999, Pages 88-93

  Burbach, Guido ^a   May, Jürgen ^a   Harms, Gundel ^a   Bienzle, Ulrich ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; HOST RESISTANCE; HUMAN; LEISHMANIASIS; PREVALENCE; REVIEW; AIDS RELATED COMPLEX; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS;

ANTIPROTOZOAL AGENT;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIPROTOZOAL AGENTS; HUMANS; LEISHMANIASIS; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, MUCOCUTANEOUS; LEISHMANIASIS, VISCERAL;

EID: 0033613567     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024248     Document Type: Review

References (30)

1. 1 Bailey, G. G., M. A. Pitt, A. Curry, N. Y. Haboubi, J. R. Tuffin, B. K. Mandal: Leishmaniasis of the tongue treated with liposomal amphotericin Brit. J. Infect. 28 (1994), 327-331.
2. 2 Bienzle, U., F. Ebert, M. Dietrich: Cutaneous leishmaniasis in Eastern Saudi Arabia. Tropenmed. Parasit. 29 (1978), 188-193.
3. 3 Bryceson, A. D., A. Murphy, A. H. Moody: Treatment of Old World cutaneous leishmaniasis with aminosidine ointment. Trans. Roy. Soc. Trop. Med. Hyg. 88 (2) (1994), 226-228.
4. 4 Carvalho, E. M., A. Baral, J. M. L. Costa, A. Bittencourt, P. Marsden. Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis. Acta trop. 56 (1994), 315-325.
5. 5 Dauden, E., P. F. Penas, L. Rios, M. Jimenez, J. Fraga, J. Alvar, A. Garcia-Diez: Leishmaniasis presenting as a dermatomyositis-like eruption in AIDS. J. Amer. Acad. Dermatol. 35 (1996), 316-319.
6. 6 Davidson, R. N., L. Di Martino, L. Gradoni, R. Giachino, R. Russo, G. B. Gaeta, R. Pempinillo, S. Scott, F. Raimondi, A. Cascio, R. Prestileo, L. Caldeira, R. J. Wilkinson, A. D. M. Bryceson: Liposomalamphotericin B (AmBisome) in mediterranean visceral leishmaniasis: a multicentre trial. Quart. J. Med. 87 (1994), 75-81.
7. 7 Davidson, R. N., R. Russo: Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B. Clin infect. Dis. 19 (1994), 560-564.
8. 8 Davidson, R. N., L. Di Martino, L. Gradoni, R. Giachino, G. B. Gaeta, R. Pempinello, S. Scotti, A. Cascio, E. Castagnola, A. Maisto, M. Gramiccia, D. Di Caprio, R. J. Wilkinson, A. D. M. Bryceson: Short course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome). Clin. infect. Dis. 22 (1996), 938-943.
9. 9 Dogra, J.: A double-blind study on the efficacy of dapsone in cutaneous leishmanisis. Trans. Roy. Soc. Trop. Med. Hyg. 85 (1991) 212-213.
10. 10 Gradoni, L., M. Gramiccia Leishmania infantum tropism. Parasitology today 10 (1994), 264-267.
11. 11 Gradoni, L., G. B. Gaeta, G. Pellizzer, A. Maisto, A. Scalone: Mediterranean visceral leishmaniasis in pregnancy. Scand. J. infect. Dis. 26 (1994), 627-629.
12. 12 Gradoni, L., A. D. M. Bryceson, P. Desjeux: Treatment of mediterranean visceral leishmaniasis. Bull. WHO 79 (1995), 191-197.
13. 13 Grant, A., P. D. R. Spraggs, H. R. Grant, A. D. M. Bryceson: Laryngeal leishmaniasis. J. Laryngol. Otol. 108 (1994), 1086-1088.
14. 14 Harms, G., U. Bienzle: Leishmaniose. In Lang, W. (Hrsg.): Tropenmedizin in Klinik und Praxis (Thieme: Stuttgart 1996), 37-53.
15. 15 Harms, G., U. Bienzle, K. F. Schaller: Leishmaniasis. In Knobloch, J. (Hrsg): Tropen- und Reisemedizin (Fischer: Jena 1996), 106-117.
16. 16 Harms, G., A. K. Chehade, M. Douba, M. Roepke, A. Mouakeh, F. Rosenkaimer, U. Bienzle: A randomized trial comparing a pentavalent antimonial drug and recombinant interferon in the local treatment of cutaneous leishmaniasis. Trans. Roy. Soc. Trop. Med. Hyg. 85 (1991), 214-216.
17. 17 Herwaldt, B. L., J. D. Berman: Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Amer. J. trop. Med. Hyg. 46 (1992), 296-306.
18. 18 Krause, G., A. Kroeger: Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride. Trans. Roy. Soc. Trop. Med. Hyg. 88 (1994), 92-94.
19. 19 Menzel, S., U. Bienzle: Antibody response in patients with cutaneous Leishmaniasis of the Old World. Tropenmed. Parasit. 29 (1978), 194-197.
20. 20 Mishra, M., U. K. Biswas, A. M. Jha, A. B. Khan: Amphotericin versus sodium stibogluconate in first-line treatment of Indian Kala-Azar. Lancet 344 (1994), 1599-1600.
21. 21 Moll, H.: Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis. Immunol. today 14 (1993), 383-386.
22. 22 Nandy, A.: Leishmanial blepharo-conjunctivitis. Trop. Geogr. Med. 43 (1994), 303-306.
23. 23 Ritter, U., H. Moll, T. Laskay, E. B. Brscker, O. Velazco, I. Becker, R. Gillitzer: Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J. infect. Dis. 173 (1996), 699-709.
24. 24 Russo, R., L. V. Nigro, S. Minniti, A. Montineri, L. Gradoni, L. Caldeira R. N. Davidson: Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome). J. Infect. 32 (1996), 133-137.
25. 25 Sacks, D. L., R. T. Kenney, R. D. Kreutzer, C. L. Jaffe, A. K. Gupta, M. C. Sharma, S. P. Sinha, F. A. Neva, R. Saran: Indian kala-azar caused by Leishmania tropica. Lancet 345 (1995), 959-960.
26. 26 Seaman, J., D. Pryce, D. Sondorp, A. Moody, A. D. M. Bryceson, R. N. Davidson: Epidemic visceral leishmaniasis in Sudan. J. infect. Dis. 168 (1993), 715-720.
27. 27 Stenger, S., N. Donhauser, H. Thuering, M. Roellinghoff, C. Bogdan: Reactivation of latent Leishmaniasis by inhibition of inducible nitric oxide synthase. J. exp. Med. 183 (1996), 1501-1514.
28. 28 Teklemariam, S., A. G. Hiwot, D. Frommel, T. L. Miko, G. Ganglov, A. D. M. Bryceson: Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused by Leishmania aethiopica. Trans. Roy. Soc.Trop. Med. Hyg. 88 (1994), 334-339.
29. 29 WHO: Epidemiological Analysis of 692 Retrospective Cases of Leishmania/HIV Coinfection (World Health Organisation: Geneva 1996).
30. 30 Zwingenberger, K., G. Harms, C. Pedrosa, S. Omena, B. Sandkamp, S. Neifer: Determinants of the immune response in visceral leishmaniasis. Clin. Immunol. Immunopathol. 57 (1990), 242-249.